H Lundbeck A/S Equity 2024

H Lundbeck A/S Aktienanalyse

What does H Lundbeck A/S do?

H Lundbeck A/S is a Danish company that was founded in 1915 by Hans Lundbeck. Since its inception, the company has focused on researching and developing medications that improve the lives of people with neuropsychiatric disorders. Lundbeck's business model is based on a clear strategy and a strong focus on the research and development of pharmaceuticals. The company has four main therapy areas: depression, anxiety disorders, Alzheimer's, and Parkinson's. Lundbeck products are sold in over 100 countries worldwide and are known for their effectiveness and high quality. Over the years, Lundbeck has also focused on developing innovative treatment methods, including research on new drugs and therapies based on neurotransmitters such as serotonin, dopamine, and norepinephrine. With the acquisition of Alder BioPharmaceuticals in 2019, Lundbeck also expanded its portfolio in the field of migraine therapy. Some of Lundbeck's most well-known products include Lexapro, Cipralex, Selincro, Abilify Maintena, and Brintellix. These medications are used in the treatment of depression, anxiety disorders, alcoholism, bipolar disorders, and migraines. In addition to selling medications, Lundbeck also provides training and support for healthcare professionals and patients. Lundbeck is also distinguished by its commitment to social engagement and works closely with nonprofit organizations to raise awareness of neuropsychiatric disorders. The company has also launched various programs to improve access to medical care in particularly affected regions. In 2020, Lundbeck exceeded 18,000 employees worldwide and had a revenue of 16.6 billion Danish kroner. Lundbeck is listed on NASDAQ OMX Copenhagen and is controlled by the Lundbeck Foundation, which holds over 70% of the company's ownership. In summary, Lundbeck is a leading company in the field of neuropsychiatric medicine and is dedicated to improving the lives of people with these serious disorders. The company has made a name for itself through its successful research and development of therapies and medications, as well as its strong focus on social engagement and corporate social responsibility. H Lundbeck A/S ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing H Lundbeck A/S's Equity

H Lundbeck A/S's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding H Lundbeck A/S's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating H Lundbeck A/S's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

H Lundbeck A/S's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in H Lundbeck A/S’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about H Lundbeck A/S Stock

What is the equity of H Lundbeck A/S this year?

H Lundbeck A/S has equity of 18.28 B DKK this year.

What was the equity of H Lundbeck A/S compared to the previous year?

The equity of H Lundbeck A/S has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of H Lundbeck A/S?

A high equity is advantageous for investors of H Lundbeck A/S as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of H Lundbeck A/S?

A low equity can be a risk for investors of H Lundbeck A/S, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of H Lundbeck A/S affect the company?

An increase in equity of H Lundbeck A/S can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of H Lundbeck A/S affect the company?

A reduction in equity of H Lundbeck A/S can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of H Lundbeck A/S?

Some factors that can affect the equity of H Lundbeck A/S include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of H Lundbeck A/S so important for investors?

The equity of H Lundbeck A/S is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can H Lundbeck A/S take to change the equity?

To change equity, H Lundbeck A/S can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does H Lundbeck A/S pay?

Over the past 12 months, H Lundbeck A/S paid a dividend of 2.5 DKK . This corresponds to a dividend yield of about 1.45 %. For the coming 12 months, H Lundbeck A/S is expected to pay a dividend of 15.45 DKK.

What is the dividend yield of H Lundbeck A/S?

The current dividend yield of H Lundbeck A/S is 1.45 %.

When does H Lundbeck A/S pay dividends?

H Lundbeck A/S pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of H Lundbeck A/S?

H Lundbeck A/S paid dividends every year for the past 10 years.

What is the dividend of H Lundbeck A/S?

For the upcoming 12 months, dividends amounting to 15.45 DKK are expected. This corresponds to a dividend yield of 8.94 %.

In which sector is H Lundbeck A/S located?

H Lundbeck A/S is assigned to the 'Health' sector.

Wann musste ich die Aktien von H Lundbeck A/S kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of H Lundbeck A/S from 3/28/2022 amounting to 2 DKK, you needed to have the stock in your portfolio before the ex-date on 3/24/2022.

When did H Lundbeck A/S pay the last dividend?

The last dividend was paid out on 3/28/2022.

What was the dividend of H Lundbeck A/S in the year 2023?

In the year 2023, H Lundbeck A/S distributed 2 DKK as dividends.

In which currency does H Lundbeck A/S pay out the dividend?

The dividends of H Lundbeck A/S are distributed in DKK.